Bone marrow biopsy with immunohistochemistry confirmed a plasma-cell neoplasm, while myeloma fluorescence <i>in situ</i> hybridization (FISH) revealed 1q21 gain/amplification together with chromosome 13-related abnormalities, including RB1 deletion and D13S319 abnormality. The gene discussed is RB1; the disease is plasma cell neoplasm.